Cargando…
Synthesis and Evaluation of Novel Ligustrazine Derivatives as Multi-Targeted Inhibitors for the Treatment of Alzheimer’s Disease
A series of novel ligustrazine derivatives 8a–r were designed, synthesized, and evaluated as multi-targeted inhibitors for anti-Alzheimer’s disease (AD) drug discovery. The results showed that most of them exhibited a potent ability to inhibit both ChEs, with a high selectivity towards AChE. In part...
Autores principales: | Wu, Wenhao, Liang, Xintong, Xie, Guoquan, Chen, Langdi, Liu, Weixiong, Luo, Guolin, Zhang, Peiquan, Yu, Lihong, Zheng, Xuehua, Ji, Hong, Zhang, Chao, Yi, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222487/ https://www.ncbi.nlm.nih.gov/pubmed/30301153 http://dx.doi.org/10.3390/molecules23102540 |
Ejemplares similares
-
Synthesis and Discovery of Ligustrazine–Heterocycle Derivatives as Antitumor Agents
por: Ma, Shitang, et al.
Publicado: (2022) -
Synthesis and Biological Evaluation of New Ligustrazine Derivatives as Anti-Tumor Agents
por: Wang, Penglong, et al.
Publicado: (2012) -
Design, Synthesis and Biological Evaluation of Ligustrazine-Flavonoid Derivatives as Potential Anti-Tumor Agents
por: Wang, Hui, et al.
Publicado: (2018) -
A Series of New Ligustrazine-Triterpenes Derivatives as Anti-Tumor Agents: Design, Synthesis, and Biological Evaluation
por: Xu, Bing, et al.
Publicado: (2015) -
Amino Acid Derivatives of Ligustrazine-Oleanolic Acid as New Cytotoxic Agents
por: Chu, Fuhao, et al.
Publicado: (2014)